JSON twin: https://www.healthaidb.com/software/us2-v1.json
Us2.ai
https://us2.ai/wp-content/uploads/2025/06/Us2.ai-Product-Brochure-Full-ver..pdf
Us2.v1 is an AI-driven software that automatically processes transthoracic echocardiography (2D, M-mode and Doppler) to produce measurements and a structured report to support cardiology clinicians and sonographers.
Us2.v1 (by Us2.ai) is a validated, regulatory-cleared (FDA 510(k), CE Mark IIb) automated echocardiography analysis platform that recognises standard TTE views, performs 2D, M‑mode and spectral/tissue Doppler measurements across all four chambers, and outputs editable annotations and reports (CSV, DICOM SR, PDF). It is deployable on cloud, hybrid, or local appliances and integrates with PACS/CIS and AI marketplaces; intended for adult transthoracic studies and not validated for complex congenital, valve, pericardial disease or intracardiac lesions.
unknown
2017
P1872
2025-09-07
commercial proprietary
Subscription pricing; typically tiered / based on number of analyses — contact vendor for commercial pricing and trial info
subscription
2021
product
1.0
{
"company_name": "Us2.ai",
"company_url": "https://us2.ai/",
"company_offices": [
"Singapore"
],
"company_founding": "2017",
"product_url": "https://us2.ai/wp-content/uploads/2025/06/Us2.ai-Product-Brochure-Full-ver..pdf",
"categories": [
"clinical",
"diagnostic",
"imaging",
"cardiology",
"decision support",
"AI/ML"
],
"market_segment": [
"enterprise",
"provider",
"hospital",
"point-of-care"
],
"links": [
"https://us2.ai/",
"https://us2.ai/about/",
"https://us2.ai/wp-content/uploads/2025/06/Us2.ai-Product-Brochure-Full-ver..pdf",
"https://www.accessdata.fda.gov/cdrh_docs/pdf21/K210791.pdf",
"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210791",
"https://radiology.healthairegister.com/products/us2ai-v1/",
"https://healthairegister.com/radiology/products/us2ai-v1",
"https://www.dicardiology.com/content/fda-clears-fully-automated-cardiac-ultrasound-solution-measure-2d-and-doppler",
"https://xrayinterpreter.com/fda/K210791"
],
"summary": "Us2.v1 is an AI-driven software that automatically processes transthoracic echocardiography (2D, M-mode and Doppler) to produce measurements and a structured report to support cardiology clinicians and sonographers.",
"description": "Us2.v1 (by Us2.ai) is a validated, regulatory-cleared (FDA 510(k), CE Mark IIb) automated echocardiography analysis platform that recognises standard TTE views, performs 2D, M‑mode and spectral/tissue Doppler measurements across all four chambers, and outputs editable annotations and reports (CSV, DICOM SR, PDF). It is deployable on cloud, hybrid, or local appliances and integrates with PACS/CIS and AI marketplaces; intended for adult transthoracic studies and not validated for complex congenital, valve, pericardial disease or intracardiac lesions.",
"target_users": [
"cardiologists",
"echocardiography sonographers",
"cardiac imaging specialists",
"radiologists",
"clinical administrators"
],
"specialties": [
"cardiology",
"echocardiography",
"cardiac imaging",
"heart failure",
"pulmonology (pulmonary hypertension assessment)"
],
"regions_available": [
"United States",
"Canada",
"European Union",
"Australia",
"New Zealand",
"Singapore"
],
"languages_supported": [
"English"
],
"pricing_model": "subscription",
"pricing_details": "Subscription pricing; typically tiered / based on number of analyses — contact vendor for commercial pricing and trial info",
"license": "commercial proprietary",
"deployment_model": [
"cloud (SaaS)",
"on_prem"
],
"os_platforms": [
"Web"
],
"features": [
"Automated analysis of transthoracic cardiac ultrasound images",
"Automated 2D measurements (cardiac chamber volumes and dimensions)",
"Automated Doppler measurement analysis",
"M-mode measurement automation (e.g., TAPSE)",
"Automatic view recognition and classification",
"DICOM image post‑processing and quantification",
"Automated report generation for echocardiography",
"Workflow integration for clinical review",
"Quality control / measurement reproducibility tracking",
"Detection/assist features for specific pathologies (e.g., cardiac amyloidosis — announced capability)"
],
"optional_modules": [],
"integrations": [
"PACS (DICOM archive)",
"POCUS / ultrasound device workflows",
"TeraRecon (Eureka Cardio Suite partnership)",
"Clinical imaging viewers / post-processing platforms"
],
"data_standards": [
"DICOM"
],
"api_available": "unknown",
"system_requirements": "",
"compliance": [
"FDA 510(k) clearance (K210791)",
"CE mark"
],
"certifications": [
"FDA 510(k)",
"CE mark"
],
"security_features": [
"Encryption (in transit / at rest)",
"Audit logs",
"Role-based access controls (RBAC)"
],
"privacy_features": [
""
],
"data_residency": "",
"customers": [
"Brigham and Women's Hospital",
"Endeavor Health (pilot)",
"Health systems using Fujifilm LISENDO customers (via partnership)"
],
"user_reviews": [],
"ratings": [
"FDA 510(k) cleared (K210791) - Decision Date 2021-07-27 (U.S. FDA)",
"CE marked (EU) for echocardiography decision support (press releases, 2023+)"
],
"support_channels": [
"email",
"phone",
"chat",
"ticketing",
"community"
],
"training_options": [
"documentation",
"webinars",
"live_online",
"onsite"
],
"release_year": "2021",
"integration_partners": [
"Fujifilm Healthcare",
"Aidoc",
"Viz.ai",
"Blackford Analysis",
"GE (Vivid integration / Us2.connect workflows)",
"PACS/VNA vendors (DICOM workflows)",
"Cardiac imaging core labs (implementation partner example: Brigham and Women's Cardiac Imaging Core Laboratory)"
],
"id": "P1872",
"slug": "us2-v1",
"type": "product",
"version": "1.0",
"last_updated": "2025-09-07",
"links_json": {
"self": "https://www.healthaidb.com/software/us2-v1.json"
}
}